Communiqués Arctic Bioscience

Actions

ABS

NO0010859580

Produits pharmaceutiques

Marché Fermé - Oslo Bors 16:45:00 17/09/2026			Varia. 5j.	Varia. 1 janv.
2,800 ^NOK	+0,36%		+0,72%	-14,63%

27/08	Arctic Bioscience AS publie ses résultats pour le semestre clos le 30 juin 2026	CI
27/08	Arctic Bioscience AS publie ses prévisions de chiffre d'affaires pour l'exercice 2026	CI

Communiqués

27/08	Arctic Bioscience - Strong revenue growth and new data on HRO350 complementing the HeROPA trial results	AQ
20/08	Arctic Bioscience - Invitation to presentation of half year 2026 results	AQ
05/08	Arctic Bioscience - Data on systemic inflammation published in Frontiers in Medicine	AQ
27/05	Arctic Bioscience - Minutes of the Annual General Meeting	AQ
13/05	Arctic Bioscience - Notice of Annual General Meeting on 27 May 2026	AQ
08/05	Arctic Bioscience : Poster – EADV spring 2026	PU
08/05	Arctic Bioscience presents HeROPA data at EADV in Athens	AQ
07/05	Arctic Bioscience : Consolidated 2025 Annual Report	PU
07/05	Arctic Bioscience - Annual report 2025	AQ
30/04	Arctic Bioscience : Presentation of Q1-2026 update	PU
30/04	Arctic Bioscience - 78% growth in Nutra revenues	AQ
24/04	Arctic Bioscience - Invitation to presentation of Q1 2026 operational update	AQ
01/04	Arctic Bioscience - Primary insiders who have provided bank guarantee	AQ
01/04	Arctic Bioscience - New long-term financing	AQ
19/03	Arctic Bioscience - New peer-reviewed study shows herring roe phospholipids stimulate anti-inflammatory pathways in cells	AQ
26/02	Arctic Bioscience : Presentation of Q4-2025 update	PU
26/02	Arctic Bioscience - Q4 2025 Operational update - Positive outlook for 2026	AQ
23/02	Arctic Bioscience - Invitation to presentation of Q4 2025 operational update	AQ
29/01	Arctic Bioscience invited to present at the Glaucoma 360 New Horizons Forum	AQ
17/12	Arctic Bioscience - Share capital increase registered	AQ
12/12	Arctic Bioscience - Board approval of share capital increase related to conversion of debt	AQ
09/12	Arctic Bioscience - Exercise of right to convert debt and issuance of shares	AQ
11/11	Arctic Bioscience - Minutes of the Extraordinary General Meeting	AQ
10/11	Css-12qhwz2{background:url(https://backend.arctic-bioscience.com/wp-content/uploads/2021/04/cloud-download.png) no-repeat;float:left;width:24px;height:24px;margin-right:10px;}Presentation of Q3-2025 update	PU
10/11	Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation	AQ